Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial
Articles > Article · 2019
Authors: Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun, Kıvanç YÜKSEL
Clinical Drug Investigation, International, WoS, 2019, vol 39, pp 991-1001